7ORZ
Crystal structure of UDP-N-acetylenolpyruvoylglucosamine reductase (MurB) from Pseudomonas aeruginosa in complex with FAD and a pyrazole derivative (fragment 18)
Summary for 7ORZ
| Entry DOI | 10.2210/pdb7orz/pdb |
| Related | 7OR2 |
| Descriptor | UDP-N-acetylenolpyruvoylglucosamine reductase, 1-phenyl-5-(trifluoromethyl)pyrazole-4-carboxylic acid, GLYCEROL, ... (5 entities in total) |
| Functional Keywords | peptidoglycan-biosynthesis, fragment based drug discovery, oxidoreductase |
| Biological source | Pseudomonas aeruginosa PAO1 |
| Total number of polymer chains | 1 |
| Total formula weight | 38594.41 |
| Authors | Acebron-Garcia de Eulate, M.,Blundell, T.L.,Kim, S.Y.,Mendes, V.,Abell, C. (deposition date: 2021-06-06, release date: 2021-11-03, Last modification date: 2024-01-31) |
| Primary citation | Acebron-Garcia-de-Eulate, M.,Mayol-Llinas, J.,Holland, M.T.O.,Kim, S.Y.,Brown, K.P.,Marchetti, C.,Hess, J.,Di Pietro, O.,Mendes, V.,Abell, C.,Floto, R.A.,Coyne, A.G.,Blundell, T.L. Discovery of Novel Inhibitors of Uridine Diphosphate- N -Acetylenolpyruvylglucosamine Reductase (MurB) from Pseudomonas aeruginosa , an Opportunistic Infectious Agent Causing Death in Cystic Fibrosis Patients. J.Med.Chem., 65:2149-2173, 2022 Cited by PubMed Abstract: is of major concern for cystic fibrosis patients where this infection can be fatal. With the emergence of drug-resistant strains, there is an urgent need to develop novel antibiotics against . MurB is a promising target for novel antibiotic development as it is involved in the cell wall biosynthesis. MurB has been shown to be essential in , and importantly, no MurB homologue exists in eukaryotic cells. A fragment-based drug discovery approach was used to target MurB. This led to the identification of a number of fragments, which were shown to bind to MurB. One fragment, a phenylpyrazole scaffold, was shown by ITC to bind with an affinity of = 2.88 mM (LE 0.23). Using a structure guided approach, different substitutions were synthesized and the initial fragment was optimized to obtain a small molecule with = 3.57 μM (LE 0.35). PubMed: 35080396DOI: 10.1021/acs.jmedchem.1c01684 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.85 Å) |
Structure validation
Download full validation report






